Article

American Health Assistance Foundation research grants available

The American Health Assistance Foundation (AHAF) is accepting proposals for research grants related to age-related macular degeneration (AMD) and glaucoma. The 501(c)3 nonprofit organization supports research leading to advances in the prevention and treatment of age-related diseases.

The American Health Assistance Foundation (AHAF) is accepting proposals for research grants related to age-related macular degeneration (AMD) and glaucoma. The 501(c)3 nonprofit organization supports research leading to advances in the prevention and treatment of age-related diseases.

In the area of AMD research, the duration and value of standard awards is $100,000 over 2 years. Letters of intent must be received by July 11; full applications are due Oct. 18.

In the area of national glaucoma research, the duration and value of such standard awards is $90,000 over 2 years. Full applications are due Nov. 16.

All research proposals are evaluated on the basis of scientific merit and their relevance to the cause, prevention, and treatment of diseases specified in the programs. Submitted proposals are subject to peer review by a qualified scientific review committee consisting of academic and clinical researchers from within the focus disease field.

Support is available to U.S. and international researchers pursuing innovative research leading to greater understanding of and therapeutic options for the treatment of these diseases.

AHAF does not provide support for large equipment purchases, construction or building expenses, or institutional overhead costs. For application instructions and more information, contact AHAF by phone at 301/948-3244 or online at www.ahaf.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.